scholarly article | Q13442814 |
P50 | author | Jaclyn S Pearson | Q58204671 |
Gad Frankel | Q63865535 | ||
Elizabeth L. Hartland | Q47502191 | ||
P2093 | author name string | Patrice Riedmaier | |
Olivier Marchès | |||
P2860 | cites work | NleG Type 3 effectors from enterohaemorrhagic Escherichia coli are U-Box E3 ubiquitin ligases | Q21131552 |
A bacterial E3 ubiquitin ligase IpaH9.8 targets NEMO/IKKgamma to dampen the host NF-kappaB-mediated inflammatory response | Q22001534 | ||
A bacterial effector targets host DH-PH domain RhoGEFs and antagonizes macrophage phagocytosis | Q24304013 | ||
A Salmonella type III secretion effector interacts with the mammalian serine/threonine protein kinase PKN1 | Q24316986 | ||
PROSITE, a protein domain database for functional characterization and annotation | Q24644916 | ||
A unique signature identifies a family of zinc-dependent metallopeptidases. | Q54672503 | ||
Citrobacter rodentium virulence in mice associates with bacterial load and the type III effector NleE | Q57676051 | ||
Enteropathogenic and enterohaemorrhagic Escherichia coli : more subversive elements | Q59307481 | ||
Crystal structure of enteropathogenic Escherichia coli intimin-receptor complex | Q27625285 | ||
Metalloprotease type III effectors that specifically cleave JNK and NF-κB | Q28116010 | ||
The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5 | Q28185796 | ||
NF-kappaB regulation in the immune system | Q28205043 | ||
Cytoplasmic flagellin activates caspase-1 and secretion of interleukin 1beta via Ipaf | Q28506503 | ||
The pathogenic E. coli type III effector EspZ interacts with host CD98 and facilitates host cell prosurvival signalling | Q29568915 | ||
Yeast functional genomic screens lead to identification of a role for a bacterial effector in innate immunity regulation | Q33274199 | ||
Secretion of flagellin by the LEE-encoded type III secretion system of enteropathogenic Escherichia coli | Q33406647 | ||
The T3SS effector EspT defines a new category of invasive enteropathogenic E. coli (EPEC) which form intracellular actin pedestals | Q33518483 | ||
The type III effectors NleE and NleB from enteropathogenic E. coli and OspZ from Shigella block nuclear translocation of NF-kappaB p65. | Q33582255 | ||
Innate immune detection of the type III secretion apparatus through the NLRC4 inflammasome | Q33733606 | ||
NleH effectors interact with Bax inhibitor-1 to block apoptosis during enteropathogenic Escherichia coli infection | Q33733678 | ||
Genomic characterization of the Yersinia genus | Q33762297 | ||
NleC, a type III secretion protease, compromises NF-κB activation by targeting p65/RelA | Q33780981 | ||
Virulence is positively selected by transmission success between mammalian hosts | Q34003664 | ||
The Shigella flexneri effector OspG interferes with innate immune responses by targeting ubiquitin-conjugating enzymes | Q34048081 | ||
The draft genome sequence of Arsenophonus nasoniae, son-killer bacterium of Nasonia vitripennis, reveals genes associated with virulence and symbiosis | Q34099527 | ||
Binding to Na(+) /H(+) exchanger regulatory factor 2 (NHERF2) affects trafficking and function of the enteropathogenic Escherichia coli type III secretion system effectors Map, EspI and NleH. | Q34462401 | ||
Essential role of the type III secretion system effector NleB in colonization of mice by Citrobacter rodentium | Q34492843 | ||
Emergence, distribution, and molecular and phenotypic characteristics of Salmonella enterica serotype 4,5,12:i:-. | Q35267925 | ||
Cleavage of p65/RelA of the NF-kappaB pathway by Chlamydia | Q35669819 | ||
Bacterial peptidases | Q35924173 | ||
Type III secretion systems and disease | Q36969851 | ||
Inhibition of NF-κB Signaling in Human Dendritic Cells by the Enteropathogenic Escherichia coli Effector Protein NleE | Q39656775 | ||
The phosphothreonine lyase activity of a bacterial type III effector family | Q40170436 | ||
An injected bacterial effector targets chromatin access for transcription factor NF-kappaB to alter transcription of host genes involved in immune responses | Q40198172 | ||
Role of Shiga toxin versus H7 flagellin in enterohaemorrhagic Escherichia coli signalling of human colon epithelium in vivo. | Q40293264 | ||
AIP56, a novel plasmid-encoded virulence factor of Photobacterium damselae subsp. piscicida with apoptogenic activity against sea bass macrophages and neutrophils. | Q40355811 | ||
Characterization of two non-locus of enterocyte effacement-encoded type III-translocated effectors, NleC and NleD, in attaching and effacing pathogens | Q40380291 | ||
EspM2 is a RhoA guanine nucleotide exchange factor | Q40593889 | ||
Binding of intimin from enteropathogenic Escherichia coli to Tir and to host cells | Q40958561 | ||
The type III secretion effector NleE inhibits NF-kappaB activation | Q41893338 | ||
Proteasome-independent degradation of canonical NFkappaB complex components by the NleC protein of pathogenic Escherichia coli | Q42177912 | ||
The ex vivo response of human intestinal mucosa to enteropathogenic Escherichia coli infection | Q42287928 | ||
Bacteria hijack integrin-linked kinase to stabilize focal adhesions and block cell detachment. | Q45986472 | ||
Enteropathogenic E. coli (EPEC) transfers its receptor for intimate adherence into mammalian cells | Q48042079 | ||
Type III secretion effectors of the IpaH family are E3 ubiquitin ligases | Q50066742 | ||
Toll-like receptor 4, but not toll-like receptor 2, is a signaling receptor for Escherichia and Salmonella lipopolysaccharides | Q50118523 | ||
Muramylpeptide shedding modulates cell sensing of Shigella flexneri. | Q54430471 | ||
A cloned pathogenicity island from enteropathogenic Escherichia coli confers the attaching and effacing phenotype on E. coli K-12. | Q54574143 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Escherichia coli | Q25419 |
NF-κB | Q411114 | ||
Enteropathogenic Escherichia coli | Q13419512 | ||
enteropathogen | Q63500873 | ||
P304 | page(s) | 219-230 | |
P577 | publication date | 2011-02-22 | |
P1433 | published in | Molecular Microbiology | Q6895967 |
P1476 | title | A type III effector protease NleC from enteropathogenic Escherichia coli targets NF-κB for degradation | |
P478 | volume | 80 |
Q38164827 | 'Drugs from bugs': bacterial effector proteins as promising biological (immune-) therapeutics |
Q27315131 | A Family of Salmonella Type III Secretion Effector Proteins Selectively Targets the NF-κB Signaling Pathway to Preserve Host Homeostasis |
Q58572728 | A Metalloprotease Homolog Venom Protein From a Parasitoid Wasp Suppresses the Toll Pathway in Host Hemocytes |
Q37871646 | Always one step ahead: How pathogenic bacteria use the type III secretion system to manipulate the intestinal mucosal immune system |
Q47097262 | Attaching and effacing (A/E) lesion formation by enteropathogenic E. coli on human intestinal mucosa is dependent on non-LEE effectors |
Q35191956 | Attaching and effacing bacterial effector NleC suppresses epithelial inflammatory responses by inhibiting NF-κB and p38 mitogen-activated protein kinase activation. |
Q26766446 | Bacterial Toxins as Pathogen Weapons Against Phagocytes |
Q38123136 | Bacterial interference with canonical NFκB signalling. |
Q37507829 | Bacterial virulence factor inhibits caspase-4/11 activation in intestinal epithelial cells |
Q33617012 | Bortezomib treatment produces nocifensive behavior and changes in the expression of TRPV1, CGRP, and substance P in the rat DRG, spinal cord, and sciatic nerve. |
Q38318508 | Bringing down the host: enteropathogenic and enterohaemorrhagic Escherichia coli effector-mediated subversion of host innate immune pathways |
Q59813014 | Clever Cooperation: Interactions Between EspF and Host Proteins |
Q50020373 | Cooperative Immune Suppression by Escherichia coli and Shigella Effector Proteins |
Q38718756 | Distinct Roles of the Antiapoptotic Effectors NleB and NleF from Enteropathogenic Escherichia coli |
Q40213403 | Down the rabbit hole: Is necroptosis truly an innate response to infection? |
Q41506828 | Enteropathogenic E. coli effectors EspG1/G2 disrupt microtubules, contribute to tight junction perturbation and inhibit restoration |
Q34177961 | Enteropathogenic and enterohaemorrhagic Escherichia coli: even more subversive elements |
Q42677180 | Enteropathogenic and enterohemorrhagic E. coli: ecology, pathogenesis, and evolution |
Q38696636 | Epithelial cells detect functional type III secretion system of enteropathogenic Escherichia coli through a novel NF-κB signaling pathway. |
Q91933031 | EspFu-Mediated Actin Assembly Enhances Enteropathogenic Escherichia coli Adherence and Activates Host Cell Inflammatory Signaling Pathways |
Q34198962 | EspG of enteropathogenic and enterohemorrhagic E. coli binds the Golgi matrix protein GM130 and disrupts the Golgi structure and function |
Q47351983 | Eukaryotic-like Kinase Expression in Enterohemorrhagic Escherichia coli: Potential for Enhancing Host Aggressive Inflammatory Response |
Q37987493 | Flagella and bacterial pathogenicity |
Q34263876 | Functional differences and interactions between the Escherichia coli type III secretion system effectors NleH1 and NleH2. |
Q42597736 | Functional expression, purification, and biochemical properties of subtilase SprP from Pseudomonas aeruginosa |
Q91817142 | Giardia lamblia Decreases NF-κB p65RelA Protein Levels and Modulates LPS-Induced Pro-Inflammatory Response in Macrophages |
Q38295538 | Hijacking of death receptor signaling by bacterial pathogen effectors |
Q59125893 | How a DNA mimic catches and cleaves NF-κB |
Q40604251 | Identification of a Distinct Substrate-binding Domain in the Bacterial Cysteine Methyltransferase Effectors NleE and OspZ. |
Q36466792 | Identification of an N-terminal truncation of the NF-κB p65 subunit that specifically modulates ribosomal protein S3-dependent NF-κB gene expression. |
Q38007348 | Infection strategies of enteric pathogenic Escherichia coli |
Q36032316 | Inhibition of Nuclear Transport of NF-ĸB p65 by the Salmonella Type III Secretion System Effector SpvD. |
Q37214160 | Interference with nuclear factor kappaB signaling pathway by pathogen-encoded proteases: global and selective inhibition |
Q35636588 | Manipulation of kinase signaling by bacterial pathogens |
Q35163621 | Metalloprotease NleC suppresses host NF-κB/inflammatory responses by cleaving p65 and interfering with the p65/RPS3 interaction |
Q35108874 | Microbial strategies for antagonizing Toll-like-receptor signal transduction |
Q38994595 | Modulation of host signaling in the inflammatory response by enteropathogenic Escherichia coli virulence proteins |
Q28083042 | Modulation of the host innate immune and inflammatory response by translocated bacterial proteins |
Q64063136 | NF-κB Signaling in Macrophages: Dynamics, Crosstalk, and Signal Integration |
Q36557738 | NleB, a bacterial effector with glycosyltransferase activity, targets GAPDH function to inhibit NF-κB activation |
Q42152411 | Pathogen blocks host death receptor signalling by arginine GlcNAcylation of death domains |
Q37319927 | Pathogenic Lifestyles of E. coli Pathotypes in a Standardized Epithelial Cell Model Influence Inflammatory Signaling Pathways and Cytokines Secretion |
Q58610410 | Phosphothreonine Lyase Promotes p65 Degradation in a Mitogen-Activated Protein Kinase/Mitogen- and Stress-Activated Protein Kinase 1-Dependent Manner. |
Q42860357 | Proteolytic Cleavage of NF-κB p65: A Novel Mechanism for Subversion of Innate Immune Signaling by Pathogenic E. Coli |
Q34375210 | Recent advances in understanding enteric pathogenic Escherichia coli. |
Q37899039 | Ribosomal protein s3: a multifunctional target of attaching/effacing bacterial pathogens |
Q38522801 | Role of virulence factors on host inflammatory response induced by diarrheagenic Escherichia coli pathotypes |
Q37021485 | Shiga toxin-producing Escherichia coli: factors involved in virulence and cattle colonization |
Q27688884 | Structure and mechanism of a type III secretion protease, NleC |
Q57976007 | Structure-function analyses of the bacterial zinc metalloprotease effector protein GtgA uncover key residues required for deactivating NF-κB |
Q41147661 | Substrate recognition by the zinc metalloprotease effector NleC from enteropathogenic Escherichia coli |
Q28492963 | Subtilase SprP exerts pleiotropic effects in Pseudomonas aeruginosa |
Q37951705 | Subversion of innate immune responses by bacterial hindrance of NF-κB pathway |
Q26773133 | Subverting Toll-Like Receptor Signaling by Bacterial Pathogens |
Q38689964 | T3SS-Independent Uptake of the Short-Trip Toxin-Related Recombinant NleC Effector of Enteropathogenic Escherichia coli Leads to NF-κB p65 Cleavage |
Q38643178 | Targeting of host organelles by pathogenic bacteria: a sophisticated subversion strategy |
Q27684732 | The Structure and Specificity of the Type III Secretion System Effector NleC Suggest a DNA Mimicry Mechanism of Substrate Recognition |
Q36200507 | The Type III Effector NleD from Enteropathogenic Escherichia coli Differentiates between Host Substrates p38 and JNK. |
Q42373973 | The WxxxE effector EspT triggers expression of immune mediators in an Erk/JNK and NF-κB-dependent manner |
Q34611109 | The apoptogenic toxin AIP56 is a metalloprotease A-B toxin that cleaves NF-κb P65 |
Q40071930 | The bacterial arginine glycosyltransferase effector NleB preferentially modifies Fas-associated death domain protein (FADD). |
Q38255302 | The cell death response to enteropathogenic Escherichia coli infection |
Q28478223 | The enteropathogenic E. coli (EPEC) Tir effector inhibits NF-κB activity by targeting TNFα receptor-associated factors |
Q38071791 | The impact of Toll-like receptors on bacterial virulence strategies |
Q39495822 | The pathogenic Escherichia coli type III secreted protease NleC degrades the host acetyltransferase p300. |
Q34596147 | The type III secretion effector NleF of enteropathogenic Escherichia coli activates NF-κB early during infection |
Q35947385 | Tir Triggers Expression of CXCL1 in Enterocytes and Neutrophil Recruitment during Citrobacter rodentium Infection |
Search more.